Zydus Lifesciences Limited (BOM:532321)

Zydus Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 9, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	907,472	1,013,630	497,549	356,774	451,368	273,595
Market Cap Growth	40.16%	103.72%	39.46%	-20.96%	64.98%	-22.99%
Enterprise Value	907,727	1,022,435	525,557	387,118	504,363	344,184
Last Close Price	901.65	1002.75	485.75	342.17	430.07	260.57
PE Ratio	20.00	26.26	25.38	7.95	21.16	23.25
PS Ratio	4.08	5.19	2.89	2.36	3.13	1.92
PB Ratio	3.76	4.59	2.53	1.87	3.02	2.34
P/TBV Ratio	6.66	8.48	4.28	3.40	7.04	7.61
P/FCF Ratio	-	43.67	30.01	39.56	18.50	13.50
P/OCF Ratio	-	31.40	18.50	16.95	13.70	9.33
EV/Sales Ratio	4.08	5.23	3.05	2.56	3.50	2.42
EV/EBITDA Ratio	14.38	19.45	14.87	12.21	14.77	12.47
EV/EBIT Ratio	16.35	22.53	18.42	15.65	18.44	16.38
EV/FCF Ratio	-	44.05	31.70	42.92	20.67	16.98
Debt / Equity Ratio	0.01	0.04	0.06	0.22	0.31	0.68
Debt / EBITDA Ratio	0.03	0.16	0.34	1.33	1.35	2.89
Debt / FCF Ratio	-	0.35	0.72	4.68	1.89	3.95
Asset Turnover	-	0.71	0.64	0.59	0.61	0.60
Inventory Turnover	-	1.87	1.81	1.64	1.64	1.86
Quick Ratio	-	1.30	1.05	0.96	0.57	0.62
Current Ratio	-	2.14	1.81	1.54	1.11	1.05
Return on Equity (ROE)	-	18.90%	10.82%	13.96%	16.91%	10.30%
Return on Assets (ROA)	-	10.31%	6.66%	5.98%	7.19%	5.57%
Return on Capital (ROIC)	15.04%	12.95%	8.08%	7.22%	8.71%	6.68%
Return on Capital Employed (ROCE)	-	19.00%	14.10%	12.40%	17.10%	13.60%
Earnings Yield	5.00%	3.81%	3.94%	12.58%	4.73%	4.30%
FCF Yield	-	2.29%	3.33%	2.53%	5.41%	7.41%
Dividend Yield	0.34%	0.30%	1.23%	0.73%	0.81%	1.34%
Payout Ratio	-	16.09%	13.63%	8.29%	0.07%	60.74%
Buyback Yield / Dilution	0.46%	0.37%	0.79%	-	-	-
Total Shareholder Return	0.80%	0.67%	2.03%	0.73%	0.81%	1.34%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.